CUE-101, a Novel HPV16 E7-pHLA-Il-2-Fc Fusion Protein, Enhances Tumor Antigen Specific T Cell Activation for the Treatment of HPV16-Driven Malignancies
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-3354
Full Text
Open PDFAbstract
Available in full text
Date
January 21, 2020
Authors
Publisher
American Association for Cancer Research (AACR)